Insider Transactions in Q3 2021 at Rapid Micro Biosystems, Inc. (RPID)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2021
|
Richard S Kollender Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
107,816
+6.79%
|
$0
$0.05 P/Share
|
|
Jul 19
2021
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+1.17%
|
$2,000,000
$20.0 P/Share
|
|
Jul 19
2021
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
8,334,560
+31.9%
|
-
|
|
Jul 19
2021
|
David Hirsch Director |
BUY
Conversion of derivative security
|
Indirect |
3,344,038
+49.53%
|
-
|
|
Jul 19
2021
|
Gurinder Grewal > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
27,777
+8.61%
|
-
|
|
Jul 19
2021
|
Richard S Kollender Director |
BUY
Conversion of derivative security
|
Indirect |
1,315,084
+48.92%
|
-
|
|
Jul 19
2021
|
Longitude Capital Partners Ii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+50.0%
|
$3,000,000
$20.0 P/Share
|
|
Jul 19
2021
|
Longitude Capital Partners Ii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,344,038
+49.53%
|
-
|